Published in Ann Rheum Dis on September 15, 2005
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood (2006) 2.06
T helper cytokines in dry eye disease. Exp Eye Res (2013) 0.97
Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates crescentic glomerulonephritis. Clin Exp Immunol (2009) 0.91
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clin Ophthalmol (2014) 0.89
[Sjögren's syndrome. Current aspects from a rheumatological point of view]. Z Rheumatol (2006) 0.82
The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers. Clin Exp Immunol (2006) 0.82
Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility. BMC Oral Health (2016) 0.77
Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment. Ann Rheum Dis (2006) 0.76
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol (1968) 6.61
Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum (1986) 6.11
Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science (1994) 3.57
A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol (2000) 2.21
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.97
Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol (1994) 1.89
The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients. Rheumatology (Oxford) (1999) 1.82
Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum (2000) 1.74
Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum (2001) 1.59
Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol (2004) 1.56
Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet (2003) 1.51
The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol (2002) 1.39
A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis (2001) 1.22
Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol (2002) 1.21
Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med (1975) 1.19
Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun (2002) 1.17
Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun (2003) 1.04
Th2 mediated regulation in RA and the spondyloarthropathies. Ann Rheum Dis (2002) 0.96
Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. J Autoimmun (1999) 0.94
Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol (2001) 0.93
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci (2004) 0.92
Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome. Br J Rheumatol (1998) 0.92
The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome. Rheumatology (Oxford) (2002) 0.92
Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol (1998) 0.90
T(H)1 cytokines are produced in labial salivary glands in Sjögren's syndrome, but also in healthy individuals. Scand J Rheumatol (1999) 0.89
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci (2000) 0.89
Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum (2002) 0.87
The genetics of primary Sjögren's syndrome. Curr Rheumatol Rep (2003) 0.87
Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome. Immunol Lett (1996) 0.86
Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol (2001) 0.86
Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome. Autoimmunity (2000) 0.83
Scoring of patellofemoral disorders. Arthroscopy (1993) 3.89
Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet (1987) 3.68
Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med (2011) 2.29
Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol (1998) 2.06
When do social inequalities in C-reactive protein start? A life course perspective from conception to adulthood in the Cardiovascular Risk in Young Finns Study. Int J Epidemiol (2007) 1.74
The lumbar multifidus muscle five years after surgery for a lumbar intervertebral disc herniation. Spine (Phila Pa 1976) (1993) 1.73
Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum (2001) 1.59
Cytotoxic T-cell responses to H-Y: mapping of the Ir genes. J Exp Med (1978) 1.53
Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy (2000) 1.53
Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts. J Exp Med (1978) 1.51
Uukuniemi virus maturation: immunofluorescence microscopy with monoclonal glycoprotein-specific antibodies. J Virol (1984) 1.40
Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report. Diabetes Care (1997) 1.31
Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) (2001) 1.31
Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins. Clin Exp Immunol (1987) 1.30
Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry (1999) 1.27
Cross-reactive cytotoxic responses. H-2 restricted are more specific than anti-H-2 responses. J Exp Med (1978) 1.17
Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16
Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev (2006) 1.14
Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood (1996) 1.13
Diversity of clinical spectrum of HTLV-III infection. Lancet (1985) 1.12
Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis (1999) 1.12
A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw (2000) 1.11
Allergic sensitization and microbial load--a comparison between Finland and Russian Karelia. Clin Exp Immunol (2007) 1.10
Evidence for oligomeric IgA production by peripheral rat lymph nodes. Nature (1974) 1.09
Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human monocytes. J Immunol (1992) 1.04
Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2007) 1.03
IgM-associated glomerulonephritis. Nephron (1982) 1.01
The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy (2003) 1.01
The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw (2001) 1.00
Bilateral Achilles tendon rupture: a report on two cases. Scand J Med Sci Sports (1996) 0.99
Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med (1990) 0.99
Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm (Vienna) (2007) 0.99
Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season. Clin Exp Immunol (2007) 0.99
Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis (2001) 0.98
Severe sciatica: a 13-year follow-up of 342 patients. Eur Spine J (1995) 0.97
The multifidus muscle in patients with lumbar disc herniation. A histochemical and morphometric analysis of intraoperative biopsies. Spine (Phila Pa 1976) (1986) 0.97
Signal transduction pathways leading to the production of IL-8 by human monocytes are differentially regulated by dexamethasone. Clin Exp Immunol (1992) 0.97
Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res (2000) 0.97
Reactive arthritis in a population exposed to an extensive waterborne gastroenteritis outbreak after sewage contamination in Pirkanmaa, Finland. Scand J Rheumatol (2011) 0.97
Dendritic cells in human peripheral blood: effective enrichment from the nonadherent cells. Immunol Lett (1987) 0.97
Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand (2003) 0.96
Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals. Scand J Immunol (2005) 0.96
Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy (2003) 0.96
Immune functions in homosexual men with antibodies to HTLV-III in Finland. Clin Exp Immunol (1985) 0.95
Analysis of Campylobacter jejuni antigens with monoclonal antibodies. J Clin Microbiol (1984) 0.95
Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis (2001) 0.95
Genetic differences in the cyclophosphamide-induced immune suppression: weaker suppression of T-cell cytotoxicity by cyclophosphamide activated by CBA mice. Clin Immunol Immunopathol (1980) 0.95
Activin A/erythroid differentiation factor is induced during human monocyte activation. J Exp Med (1992) 0.94
Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant (2001) 0.94
Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol Scand (2007) 0.94
High expression of the Thy-1 antigen on natural killer cells recently derived from bone marrow. Cell Immunol (1984) 0.93
Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2012) 0.93
Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome. Clin Exp Immunol (2005) 0.92
Hormonal deficiencies during and after Puumala hantavirus infection. Eur J Clin Microbiol Infect Dis (2010) 0.92
Patellofemoral relationships in recurrent patellar dislocation. J Bone Joint Surg Br (1989) 0.92
Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey. Clin Exp Immunol (2011) 0.92
Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome. Rheumatology (Oxford) (2004) 0.92
Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis (2009) 0.91
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest (2008) 0.91
Induction of beta-2-microglobulin release in vitro by chronic lymphocytic leukaemia cells: relation to total protein synthesis. Leuk Res (1999) 0.91
Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol (1996) 0.91
Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J Neuroimmunol (2004) 0.91
Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL4 genetics. Int Arch Allergy Immunol (2005) 0.91
Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure (2002) 0.90
Comparison of retinoic acid and phorbol myristate acetate as inducers of monocytic differentiation. Int J Cancer (1994) 0.89
Surgical treatment of patellar tendon pain in athletes. Br J Sports Med (1986) 0.89
Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Ann Rheum Dis (2006) 0.89
Interferon-gamma production in antigen specific T cell response: quantitation of specific mRNA and secreted protein. Scand J Immunol (1997) 0.88
High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica. Eur J Clin Microbiol Infect Dis (2011) 0.88
Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica (2000) 0.88
Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet (2005) 0.88
Membrane-associated interleukin 1 is required for the activation of T cells in the anti-CD3 antibody-induced T cell response. J Immunol (1987) 0.88
Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurol Scand (2003) 0.87
Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses. J Exp Med (1979) 0.87
Genome-wide association study does not reveal major genetic determinants for anti-cytomegalovirus antibody response. Genes Immun (2011) 0.87
Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study. J Intern Med (2009) 0.87
Natural killer (NK) cell activity during lymphatic regeneration: early appearance of Thy-1+ NK cells and highly interleukin 2-(IL 2) receptive, Thy-1- cells. J Immunol (1983) 0.87
Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. Leukemia (2002) 0.87
Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling aseptic meningitis. Arch Intern Med (2000) 0.87
Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev (2001) 0.87
Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Int Immunopharmacol (2001) 0.87
ABO blood groups and musculoskeletal injuries. Injury (1992) 0.87
Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome. Rheumatology (Oxford) (2004) 0.87
Are body mass index, waist circumference and waist-to-hip ratio associated with leptin in 90-year-old people? Eur J Clin Nutr (2013) 0.87
Connective tissue changes of the multifidus muscle in patients with lumbar disc herniation. An immunohistologic study of collagen types I and III and fibronectin. Spine (Phila Pa 1976) (1989) 0.86
Clinical findings as outcome predictors in rehabilitation of patients with sciatica. Int J Rehabil Res (1991) 0.86
Affinity and Ig classes of anti-hapten antibodies in carrier-preimmunized rats. Eur J Immunol (1973) 0.86
Fine-specificity of the immune response to oxazolone. I. Contact sensitivity and early antibodies. J Immunol (1981) 0.86
Accessory cells, dendritic cells, or monocytes, are required for the lymphokine-activated killer cell induction from resting T cell but not from natural killer cell precursors. J Immunol (1988) 0.86
C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. Atherosclerosis (2007) 0.85
A prospective study of patients with sciatica. A comparison between conservatively treated patients and patients who have undergone operation, Part II: Results after one year follow-up. Spine (Phila Pa 1976) (1990) 0.85
Pre-exposure to oxidative stress decreases the nuclear factor-kappa B-dependent transcription in T lymphocytes. J Immunol (1998) 0.85
Epistatic effects of genes encoding immunoglobulin GM allotypes and interleukin-6 on the production of autoantibodies to 60- and 65-kDa heat-shock proteins. Genes Immun (2004) 0.85
Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res (1998) 0.84